Author: John Pinching

Positive results from trial of Arecor’s insulin candidate AT247

Therapy demonstrates significantly accelerated insulin absorption and early exposure

Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode

Partnership will evaluate AI-powered technology in lung cancer care

Medicines repurposing offers new avenues for treating a range of common and rare diseases

First EU public-private collaboration for production of saRNA-based vaccines

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN